Lead product for treating Parkinson's Disease demonstrates efficacy in 3 different animal models of Parkinson's Disease: a chemically-induced model and 2 different transgenic α-synuclein mouse models.
reMYND, Bio-Incubator (Wetenschapspark)Gaston Geenslaan 1BE-3001 Leuven (Heverlee)Belgium
RPR Leuven, 0476.910.101BTW/VAT: BE0476.910.101
T +32 16 75 14 20F +32 16 75 14 email@example.com
Terms & conditions